Kyoto, Japan

Takatani Muneo

This inventor holds 1 USPTO granted patent. Top assignee: Takeda Chemical Industries, Inc.. Active years: 1995.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takatani Muneo. Retrieved from https://idiyas.com/inventor/takatani-muneo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 1995

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovator of Imidazopyridine Derivatives - Takatani Muneo

Introduction

Takatani Muneo, an accomplished inventor based in Kyoto, Japan, is known for his innovative contributions to the field of pharmaceuticals. His work primarily focuses on the development of specific compounds that play significant roles in medical advancements.

Latest Patents

Muneo holds one patent titled "Imidazopyridine derivatives and their use." This patent details a calmodulin inhibitory composition that incorporates a compound of a specific formula. Additionally, it includes an angiogenesis inhibitory composition featuring another designated compound. His research showcases the potential of these derivatives in therapeutic applications.

Career Highlights

Throughout his career, Takatani Muneo has made significant strides while working at Takeda Chemical Industries, a leading name in the pharmaceutical industry. His insight into medicinal chemistry has undoubtedly contributed to the company's success and innovation in drug development.

Collaborations

Muneo has collaborated with esteemed colleagues, including Yoshio Kozai and Kiminori Tomimatsu. Together, they have contributed to pioneering research that pushes the boundaries of pharmacology and explores new avenues for treatment and therapy.

Conclusion

Takatani Muneo's work in developing imidazopyridine derivatives exemplifies the critical intersection of innovation and medical science. His contributions hold promise for future medical breakthroughs, highlighting the importance of research and development in the pharmaceutical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…